Bohuon, 51, was formerly executive vice-president of the Abbott Corporation and president of its pharmaceutical division. In 2003, he was named the group's president for European operations and later became president of Abbott International.
Prior to that, before beginning his career at Roussel Uclaf in Morocco (and later in the Middle East), Bohuon was marketing director and then operations director of Glaxo France (1991-1995), ceo and then president of SmithKline Beecham Laboratories (1995-2001), and director of GlaxoSmithKline's commercial operations, Europe (2001-2003).
In addition to his duties as the ceo of Pierre Fabre Group, Bohuon will also act as president of Pierre Fabre Medicament.
Olivier Bohuon to join Pierre Fabre
Becomes chief executive of French pharmaceutical firm on 1 September
You may also like
Media
Cellectar Biosciences and Pierre Fabre collaborate to develop drug conjugates
Cellectar Biosciences, an oncology-focused, clinical stage biotechnology company, together with French pharmaceutical company Pierre Fabre, will extend its ongoing collaboration to develop new phospholipid drug conjugates (PDCs)
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
